• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

CNS Specialty?

anonymous

Guest
Just curious... Has anyone heard anything about what’s going to happen to CNS Specialty? Now that most CSR reps and Syneos have Vraylar... are they really needed?. It would have made more sense to give them Ubrelvy because they called on the neurologists for Namenda/ Namzaric.